TCMBANKIN000901 |
tetrahydroharmine |
(R)-Tetrahydroharmine; (+)-Tetrahydroharmine; UNII-F1Q1E0G45A component ZXLDQJLIBNPEFJ-MRVPVSSYSA-N; 1H-Pyrido(3,4-b)indole, 2,3,4,9-tetrahydro-7-methoxy-1-methyl-, (1R)-; 7759-46-8; ZINC2112084; AC1L9CA2; (1r)-tetrahydroharmine; AF812R7053; UNII-AF812R7053; CHEBI:9485; 1H-Pyrido(3,4-b)indole, 2,3,4,9-tetrahydro-7-methoxy-1-methyl-, (R)-; (1R)-7-methoxy-1-methyl-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indole; C09243; 1H-Pyrido(3,4-b)indole, 2,3,4,9-tetrahydro-7-methoxy-1-methyl-, (+)- |
C13H16N2O |
216.28 g/mol |
CC1C2=C(CCN1)C3=C(N2)C=C(C=C3)OC |
TCMBANKIN006173 |
derriscanoside a |
|
C28H32O13 |
576.5 g/mol |
CC1C(C(C(C(O1)OCC2C(C(C(C(O2)OC3=CC4=C(C=C3)C(=O)C(=CO4)C5=CC=C(C=C5)OC)O)O)O)O)O)O |
TCMBANKIN013916 |
Deoxyvasicinone |
Pyrrolo(2,1-b)quinazolin-9(1H)-one, 2,3-dihydro-; 1,2,3,10-tetrahydro-pyrrolo[2,1-b]quinazolin-9-one; AC1Q1HJF; BG00602365; BBL028460; InChI=1/C11H10N2O/c14-11-8-4-1-2-5-9(8)12-10-6-3-7-13(10)11/h1-2,4-5H,3,6-7H; AC1Q6FYI; ST50135008; 1H,2H,3H,9H-pyrrolo[2,1-b]quinazolin-9-one; SCHEMBL864139; 4-hydropyrrolidino[2,1-b]quinazolin-5-one; AKOS002210198; VARHXCYGZKSOOO-UHFFFAOYSA-N; DTXSID90201049; deoxyvasicinone; W1018; STOCK1N-00997; cid_68261; Pyrrolo[2,1-b]quinazolin-9(1H)-one, 2,3-dihydro-; MolPort-000-489-741; CHEBI:4435; 3H-Quinazolin-4-one, 2,3-trimethyleno; FCH831074; SR-01000434191; 2,3-dihydro-1H-pyrrolo[2,1-b]quinazolin-9-one\n2,3-dihydro-1H-pyrrolo[2,1-b]quinazolin-9-one\n2,3-Dihydro-1H-pyrrolo[2,1-b]quinazolin-9-one; BDBM50244216; SMR000024071; HMS2507B03; MLS000088451; MFCD00247051; STL373117; ZINC226366; NSC 159478; AC1L29DJ; BB_NC-02943; SR-01000434191-1; CHEMBL456881; NSC159478; ZINC00226366; 4CN-1561; MCULE-8877508828; NSC-159478; 530-53-0; BB_NC-1382; C10659; 2,3-Dihydro-1H-pyrrolo[2,1-b]quinazolin-9-one; Pyrrolo[2,1-b]quinazolin-9(1H)-one,2,3-dihydro-; Desoxyvasicinon; 2,3-Trimethylene-4-quinazolone; 2,3-dihydropyrrolo[2,1-b]quinazolin-9(1H)-one |
C11H10N2O |
186.21 |
C1CC2=NC3=CC=CC=C3C(=O)N2C1 |
TCMBANKIN019623 |
harpagide acetate |
harpagideacetate |
|
406.43 |
CC(=O)OCC1CC(C2C1C(OC=C2)OC3C(C(C(C(O3)CO)O)O)O)O |
TCMBANKIN021138 |
vasicinone |
|
C11H10N2O2 |
202.21 g/mol |
C1CN2C(=NC3=CC=CC=C3C2=O)C1O |
TCMBANKIN022596 |
peganol |
|
C11H12N2O |
188.23 g/mol |
C1CC2=NC3=CC=CC=C3C(N2C1)O |
TCMBANKIN026276 |
harmaline |
|
C13H14N2O |
214.26 |
CC1=NCCC2=C1NC3=C2C=CC(=C3)OC |
TCMBANKIN031080 |
tetrahydroharmol |
|
C12H14N2O |
202.25 g/mol |
CC1C2=C(CCN1)C3=C(N2)C=C(C=C3)O |
TCMBANKIN032476 |
vasicoline |
|
C19H21N3 |
291.4 g/mol |
CN(C)C1=CC=CC=C1C2CCN3C2=NC4=CC=CC=C4C3 |
TCMBANKIN035569 |
harmalol |
|
C12H12N2O |
200.24 |
CC1=NCCC2=C1NC3=C2C=CC(=C3)O |
TCMBANKIN035964 |
harmol |
|
C12H10N2O |
198.22 g/mol |
CC1=C2C(=C3C=CC(=O)C=C3N2)C=CN1 |
TCMBANKIN058633 |
peganine |
vasicine |
C11H12N2O |
188.23 |
C1CN2CC3=CC=CC=C3N=C2C1O |
TCMBANKIN059352 |
lanosterol |
LAN; (3beta)-lanosta-8,24-dien-3-ol; L5768_SIGMA; ZINC03870056; ST5309405; CHEBI:16521; Lanosta-8,24-dienol; 79-63-0; LMST01010017; (3S,5R,10S,13R,14R,17R)-17-[(1R)-1,5-dimethylhex-4-enyl]-4,4,10,13,14-pentamethyl-2,3,5,6,7,11,12,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-3-ol; lanosta-8,24-dien-3beta-ol; (3beta,5alpha)-4,4,14-trimethylcholesta-8,24-dien-3-ol; Botalan base 138; (3S,5R,10S,13R,14R,17R)-4,4,10,13,14-pentamethyl-17-[(2R)-6-methylhept-5-en-2-yl]-2,3,5,6,7,11,12,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-3-ol; Lanosta-8,24-dien-3-ol, (3.beta.)-; 4,4',14alpha-Trimethyl-5alpha-cholesta-8,24-dien-3beta-ol; 8,24-Lanostadien-3beta-ol; L1504_SIGMA; Cholesta-8,24-dien-3-ol, 4,4,14-trimethyl-, (3.beta.,5.alpha.)-; Lanster; C01724; NSC60677; LANOSTEROL; Lanosterin; 3beta-Hydroxy-8,24-lanostadiene; Lanosta-8,24-dien-3.beta.-ol |
C30H50O |
426.72 g/mol |
CC(CCC=C(C)C)C1CCC2(C1(CCC3=C2CCC4C3(CCC(C4(C)C)O)C)C)C |
TCMBANKIN060060 |
harmine |
|
C13H12N2O |
212.25 |
CC1=NC=CC2=C1NC3=C2C=CC(=C3)OC |